ANNA VALDES: Open Payments
NPI 1487372298 · HIALEAH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$758 in 25 payments from 11 companies in 2025. Trend: 2023 $361 · 2024 $516 · 2025 $758
Food & beverage: $758
| Company | Payments | Amount |
|---|---|---|
| Travere Therapeutics, Inc. | 6 | $171 |
| Novartis Pharmaceuticals Corporation | 1 | $124 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $105 |
| AstraZeneca Pharmaceuticals LP | 3 | $91 |
| Mallinckrodt Hospital Products Inc. | 2 | $65 |
| Novo Nordisk Inc | 2 | $54 |
| Calliditas Therapeutics US Inc. | 2 | $51 |
| Aurinia Pharma U.S., Inc. | 1 | $27 |
| Ardelyx, Inc. | 1 | $25 |
| OPKO Pharmaceuticals, LLC | 1 | $24 |
Products named: Fabhalta, Kerendia, ACTHAR, FARXIGA, Ozempic, TARPEYO, LOKELMA, LUPKYNIS.
Industry payments across FL — which companies pay providers there.
